Reported Earlier, TFF Pharmaceuticals Prices $4.8M Public Offering Of 1,665,219 Shares And Warrants At $2.875/Share Accompanying Warrant
Reported Earlier, TFF Pharmaceuticals Prices $4.8M Public Offering Of 1,665,219 Shares And Warrants At $2.875/Share Accompanying Warrant
TFF Pharmaceuticals announced the pricing of a public offering of an aggregate of 1,665,219 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 1,665,219 shares of common stock at a combined public offering price of $2.875 per share (or per common stock equivalent in lieu thereof) and accompanying warrant. The warrants will have an exercise price of $2.75 per share, will be exercisable immediately upon issuance and will expire five years from the date of issuance. The closing of the offering is expected to occur on or about May 1, 2024, subject to the satisfaction of customary closing conditions
TFF Pharmicals宣布公开发行总计1,665,219股普通股（或代替普通股等价物）和认股权证的定价，以每股2.875美元（或以每股普通股等价物代替）和附带的认股权证，购买最多1,665,219股普通股。认股权证的行使价为每股2.75美元，将在发行后立即行使，并将自发行之日起五年内到期。此次发行预计将于2024年5月1日左右结束，但须满足惯例成交条件
译文内容由第三方软件翻译。